There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C07K16/28
Jump to navigation
Jump to search
Pages in category "C07K16/28"
The following 59 pages are in this category, out of 59 total.
1
- 17415589. Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 17767856. ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL ENGAGERS simplified abstract (Arizona Board of Regents on Behalf of Arizona State University)
- 17769171. COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES simplified abstract (The Regents of the University of California)
- 18193062. CANCER TREATMENT COMBINATIONS simplified abstract (The Regents of the University of California)
- 18234229. METHODS FOR SENSITIZING CANCER CELLS TO T CELL-MEDIATED KILLING BY MODULATING MOLECULAR PATHWAYS simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18267257. T CELL RECRUITING POLYPEPTIDES BASED ON TCR ALPHA/BETA REACTIVITY simplified abstract (SANOFI)
- 18274979. IMMUNE RECEPTORS WITH SYNTHETIC CO-STIMULATORY DOMAINS simplified abstract (The Regents of the University of California)
- 18277914. SINGLE DOMAIN ANTIBODY AGAINST CD47 AND USE THEREOF simplified abstract (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 18277926. SINGLE DOMAIN ANTIBODY AGAINST PD-L1 AND USE THEREOF simplified abstract (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 18295036. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
- 18302738. METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY simplified abstract (The Regents of the University of California)
- 18359569. LDL RECEPTOR-DIRECTED BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18384176. INHIBITING ANTI-ENPP1 ANTIBODIES simplified abstract (The Regents of the University of California)
- 18412280. FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18438746. METHODS OF TREATING CANCER PAIN BY ADMINISTERING A PD-1 INHIBITOR simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18458657. LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY simplified abstract (Massachusetts Institute of Technology)
- 18480038. ANTIBODY FUSION PROTEIN AND RELATED COMPOSITIONS FOR TARGETING CANCER simplified abstract (Arizona Board of Regents on Behalf of Arizona State University)
- 18517327. BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF USE simplified abstract (Genentech, Inc.)
- 18546081. MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN ROR1 simplified abstract (The Regents of the University of California)
- 18550914. METHODS FOR TREATING GYNECOLOGIC CANCER USING COMBINATION THERAPY WITH ANTI-MUC16 x CD3 MULTISPECIFIC ANTIBODIES AND VEGF INHIBITORS simplified abstract (The General Hospital Corporation)
- 18552141. SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION simplified abstract (The Regents of the University of California)
- 18560003. STRUCTURE BASED ISOLATION OF PMHC-RESTRICTED ANTIBODIES simplified abstract (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY)
- 18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)
- 18568218. ANTIBODIES THAT STIMULATE NK CELL-MEDIATED CYTOTOXICITY simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18594234. ANTI-CXCR5 ANTIBODIES AND COMPOSITIONS AND USES THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18620748. Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias simplified abstract (The Trustees of the University of Pennsylvania)
- 18636947. CELL-BASED ASSAY FOR DETECTING ANTl-CD3 HOMODIMERS simplified abstract (GENENTECH, INC.)
- 18643312. BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract (The Regents of the University of California)
2
- 20240010707. De-immunized Factor VIII Molecule and Pharmaceutical Compositions Comprising the Same simplified abstract (Biotest AG)
- 20240010980. NATURAL KILLER CELLS WITH ENHANCED ACTIVITY simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 20240025963. DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES simplified abstract (2seventy bio, Inc.)
- 20240052039. PROTEIN, POLYNUCLEOTIDE, VECTOR, HOST CELL, COMPOSITION, METHOD FOR TREATING AN ILLNESS, IN-VITRO METHOD FOR PREDICTING MULTIPLE SCLEROSIS, AND USE OF A PROTEIN OR COMPOSITION simplified abstract (Fundação Oswaldo Cruz)
- 20240052392. CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION simplified abstract (GENENTECH, INC.)
B
- Biotechnology patent applications on 23rd Aug 2024
- Biotechnology patent applications on August 22nd, 2024
- Blockchain patent applications on 22nd Mar 2024
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on February 29th, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on January 25th, 2024
- Blockchain patent applications on March 21st, 2024
- Blockchain patent applications on March 7th, 2024
- Blockchain patent applications on May 16th, 2024
T
- The regents of the university of california (20240254219). NOVEL WNT AGONIST ANTIBODIES AND THERAPEUTIC USES THEREOF simplified abstract
- The regents of the university of california (20240261334). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract
- The regents of the university of california (20240293463). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract
- The regents of the university of california (20240294657). INHIBITING ANTI-ENPP1 ANTIBODIES simplified abstract
- The Regents of the University of California patent applications on August 1st, 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on August 8th, 2024
- The Regents of the University of California patent applications on September 5th, 2024
- The Trustees of Columbia University in the City of New York (20240294643). COMPOSITIONS AND METHODS FOR MODULATING CANCER IMMUNE FITNESS simplified abstract
